Skip to main content

Table 5 Immunotherapy Trials

From: The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of

Immunotherapy Trials (n) %
Immune checkpoint inhibitors 17 51.5
Vaccine 7 21.2
Adoptive cell transfer 5 15.2
Immunomodulatora 2 6.1
Oncolytic virus 2 6.1
  1. aImmunomodulators are the active agents of immunotherapy. They are a diverse array of recombinant, synthetic, and natural preparations including interleukins, cytokines, chemokines